×
For best experience we recommend to activate Javascript in your browser.
ADAM10 antibody (AA 420-641)
The Rabbit Polyclonal anti-ADAM10 antibody has been validated for WB, IHC, IP and ICC. It is suitable to detect ADAM10 in samples from Human.
Quick Overview for ADAM10 antibody (AA 420-641) (ABIN7610222)
Target
See all ADAM10 Antibodies
ADAM10
(ADAM Metallopeptidase Domain 10 (ADAM10))
Reactivity
All reactivities for ADAM10 antibodies
Human
Host
All hosts for ADAM10 antibodies
Rabbit
Clonality
All clonalities for ADAM10 antibodies
Polyclonal
Conjugate
All conjugates for ADAM10 antibodies
This ADAM10 antibody is un-conjugated
Application
All applications for ADAM10 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Product Details anti-ADAM10 Antibody
(hide)
Binding Specificity
All epitopes for ADAM10 antibodies
AA 420-641
Purpose
A Disintegrin And Metalloprotease 10 (ADAM10) Polyclonal Antibody
Sequence
Arg420~Val641
Characteristics
The A Disintegrin And Metalloprotease 10 (ADAM10) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for ADAM10
(hide)
Target
ADAM10
(ADAM Metallopeptidase Domain 10 (ADAM10))
Alternative Name
ADAM10
Gene ID
102
UniProt
O14672
Pathways
Notch Signaling , EGFR Signaling Pathway
Recently viewed
(hide)
Chat with us , powered by LiveChat